B. Riley lowered the firm’s price target on Oklo (OKLO) to $92 from $129 and keeps a Buy rating on the shares. The company reported progress across its power, fuel, and isotope businesses, including DOE approvals supporting its first Aurora plant at Idaho National Laboratory, a prepayment agreement with Meta (META) for up to 1.2 GW in Ohio, initial fuel facility construction, and key NRC and DOE milestones for Atomic Alchemy’s isotope operations, the analyst tells investors in a research note. Oklo exited the quarter with $1.4B in cash, raised an additional $1.2B post-quarter, and guided 2026 operating cash use of $80M-$100M and investing cash use of $350-$450M, the firm says.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OKLO:
- Oklo price target lowered to $65 from $91 at Goldman Sachs
- Oklo: Strengthened Liquidity and Project Progress Support Buy Rating Despite Lowered Target
- Oklo price target lowered to $125 from $175 at Canaccord
- Balanced View on Oklo: Near-Term Validation from Meta Deal vs. Long-Dated, Execution-Heavy Upside
- Oklo price target lowered to $73.50 from $95 at Citi
